ClinVar Miner

Submissions for variant NM_001605.3(AARS1):c.1632C>T (p.Asp544=)

gnomAD frequency: 0.00081  dbSNP: rs149425243
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000506789 SCV000602325 benign not specified 2017-01-31 criteria provided, single submitter clinical testing
GeneDx RCV001704658 SCV000729291 likely benign not provided 2020-08-14 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000653968 SCV000775858 benign Charcot-Marie-Tooth disease type 2 2023-12-30 criteria provided, single submitter clinical testing
Ambry Genetics RCV002461263 SCV002755351 likely benign Inborn genetic diseases 2019-07-11 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000506789 SCV005394996 likely benign not specified 2024-09-10 criteria provided, single submitter clinical testing Variant summary: AARS1 c.1632C>T alters a non-conserved nucleotide resulting in a synonymous change. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00034 in 282878 control chromosomes in the gnomAD database, including 2 homozygotes. To our knowledge, no occurrence of c.1632C>T in individuals affected with Developmental and epileptic encephalopathy, 29 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 439344). Based on the evidence outlined above, the variant was classified as likely benign.
PreventionGenetics, part of Exact Sciences RCV003960193 SCV004768744 likely benign AARS1-related disorder 2019-02-18 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.